1. Home
  2. BIO vs XP Comparison

BIO vs XP Comparison

Compare BIO & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$268.16

Market Cap

7.2B

Sector

Industrials

ML Signal

N/A

Logo XP Inc.

XP

XP Inc.

N/A

Current Price

$20.15

Market Cap

10.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BIO
XP
Founded
1952
2001
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Investment Bankers/Brokers/Service
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
10.1B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BIO
XP
Price
$268.16
$20.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$358.50
$22.67
AVG Volume (30 Days)
304.0K
6.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.97%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.51
$19.15
Revenue Next Year
$3.17
$13.67
P/E Ratio
$9.72
$11.42
Revenue Growth
N/A
N/A
52 Week Low
$211.43
$12.20
52 Week High
$343.12
$23.13

Technical Indicators

Market Signals
Indicator
BIO
XP
Relative Strength Index (RSI) 37.86 49.53
Support Level $266.71 $18.05
Resistance Level $290.01 $20.37
Average True Range (ATR) 7.21 1.08
MACD 0.67 -0.32
Stochastic Oscillator 13.13 36.69

Price Performance

Historical Comparison
BIO
XP

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

Share on Social Networks: